Adage Capital Partners Gp, L.L.C. Atai Life Sciences N.V. Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 5,434,782 shares of ATAI stock, worth $22.4 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,434,782Holding current value
$22.4 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
111Shares Held
31.3MCall Options Held
506KPut Options Held
315K-
Ubs Group Ag7.7MShares$31.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.49MShares$14.4 Million0.0% of portfolio
-
Pale Fire Capital Se Prague, 2N2.64MShares$10.9 Million0.59% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$5.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.19MShares$4.91 Million0.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $685M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...